Key result
The estimation of atenolol potency as an antagonist of beta1-adrenoceptors gave divergent results depending on whether it was pre-incubated or added after a steady-state isoprenaline response.
Blocking a steady-state agonist response to measure antagonist potency can yield erroneous results compared to pre-incubation methods in dynamic pharmacological assays.
Answers are grounded in this paper and cite their sources.
Post-steady-state antagonist addition may yield erroneous beta1-adrenoceptor potency estimates; leaves open optimal assay protocols for future studies.
The potency of the beta1-adrenoceptor antagonist atenolol was measured as an inhibitor of responses to isoprenaline in guinea-pig left atria. Measurements were made in two ways, firstly, by pre-incubating the atria with a given concentration of atenolol followed by an isoprenaline dose-response curve and, secondly, by measuring the response to isoprenaline followed by addition of atenolol. 2. It was found that the estimation of atenolol potency as an antagonist of beta1-adrenoceptors by these two methods gave divergent results. Specifically, it was found that the isoprenaline-induced increased rate of myocardial relaxation was resistant to receptor blockade. Thus, the rate-limiting step in the relaxation response was dissociated from receptor activation and therefore, could not be used for the measurement of receptor occupancy. 3. In contrast, the positive inotropic response was very responsive to receptor occupancy. However, when atenolol was used to block a steady-state isoprenaline response, there was a complicating depression of basal inotropy after receptor blockade that obfuscated measurement of receptor blockade. 4. In general, these data indicated that the blockade of a steady-state agonist response to measure the potency of an antagonist might in some cases yield erroneous results. These studies indicate some caution in the interpretation of blockade responses in pre-contracted or pre-stimulated pharmacological preparations.
No takes yet. Share an insight, caveat, or question.
Corsi et al. (2000) studied this question. Atenolol was evaluated on Potency of atenolol as an antagonist of beta1-adrenoceptors. The estimation of atenolol potency as an antagonist of beta1-adrenoceptors gave divergent results depending on whether it was pre-incubated or added after a steady-state isoprenaline response.
Synapse has enriched 10 related papers. Consider them for comparative context: